According to Ionis Pharmaceuticals 's latest financial reports the company's total assets are $2.99 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $2.99 B | 18% |
2022-12-31 | $2.53 B | -2.98% |
2021-12-31 | $2.61 B | 9.29% |
2020-12-31 | $2.38 B | -26.08% |
2019-12-31 | $3.23 B | 21.19% |
2018-12-31 | $2.66 B | 101.68% |
2017-12-31 | $1.32 B | 44.97% |
2016-12-31 | $0.91 B | -3.74% |
2015-12-31 | $0.94 B | -0.83% |
2014-12-31 | $0.95 B | 12.83% |
2013-12-31 | $0.84 B | 55.25% |
2012-12-31 | $0.54 B | 12.54% |
2011-12-31 | $0.48 B | -11.91% |
2010-12-31 | $0.55 B | -16.24% |
2009-12-31 | $0.65 B | 14.46% |
2008-12-31 | $0.57 B | 121.8% |
2007-12-31 | $0.25 B | 1.15% |
2006-12-31 | $0.25 B | 53.82% |
2005-12-31 | $0.16 B | -20.18% |
2004-12-31 | $0.20 B | -37.77% |
2003-12-31 | $0.33 B | -23.65% |
2002-12-31 | $0.43 B | 5.18% |
2001-12-31 | $0.41 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | $0.27 M | -99.99% | Bahamas |
NRC Health
NRC | $0.12 B | -95.91% | ๐บ๐ธ USA |